Novartis: all 3,900 studies
Page 27 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure ChamberCompletedNCT01804400Phase 2
- Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in ChinaCompletedNCT01796639
- Study of FTY720 in Patients With UveitisWithdrawnNCT01791192Phase 2
- Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in CombinationCompletedNCT01772836Phase 1
- Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung CancerCompletedNCT01772797Phase 1
- Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in PatientsCompletedNCT01769768Phase 1
- Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell DonorsCompletedNCT01766934
- Effect of Hepatic Impairment on LDE225..CompletedNCT01764776Phase 1
- A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid TumorsCompletedNCT01760525Phase 1
- Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During RamadanCompletedNCT01758380Phase 4
- Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICSWithdrawnNCT01757015Phase 3
- Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult SubjectsCompletedNCT01751269Phase 1
- Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal VolunteersCompletedNCT01748864Phase 1
- Compare the Effect of a Remote Monitoring System Using the EXACT Tool to Reduce Hospitalizations Due to Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. EXACT = Exacerbations of Chronic Pulmonary Disease Tool.CompletedNCT01744028Phase 1
- A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST PatientsCompletedNCT01735968Phase 1
- A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia PatientsCompletedNCT01730768Phase 2
- A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary MyelofibrosisTerminatedNCT01730248Phase 1
- Pharmacokinetic Study of BKM120 in Subjects With Hepatic ImpairmentCompletedNCT01727128Phase 1
- An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years OldWithdrawnNCT01724138Phase 4
- Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE StudiesCompletedNCT01715779
- Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active ControlWithdrawnNCT01715311Phase 4
- EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related OutcomesTerminatedNCT01711606
- Effect of an Individualized Patient Support Program on Treatment Satisfaction in Fingolimod-treated Patients With RRMSWithdrawnNCT01709812Phase 4
- Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects 2 Years of Age and OlderWithdrawnNCT01705379
- A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic AsthmaCompletedNCT01703312Phase 1/2
- Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult SubjectsCompletedNCT01702649Phase 1
- Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.CompletedNCT01700270Phase 1
- A Phase I Study of Oral BGJ398 in Asian PatientsCompletedNCT01697605Phase 1
- Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT01691807Phase 1
- A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComaWithdrawnNCT01690871Phase 2
- Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell CarcinomaCompletedNCT01689766Phase 2
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary TumorsCompletedNCT01689727Phase 2
- Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial CarcinomaCompletedNCT01689714Phase 2
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell CarcinomaCompletedNCT01689662Phase 2
- Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer PatientsCompletedNCT01689636Phase 1
- A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)TerminatedNCT01688791Phase 1
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial CancerCompletedNCT01686256Phase 1
- Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid TumorCompletedNCT01684098Phase 2
- Remission of ICD by Switching Dopamine Agonist to Levodopa/CarbidopaCompletedNCT01683253Phase 4
- An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)WithdrawnNCT01676948Phase 3
- Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's DiseaseCompletedNCT01673724Phase 4
- Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy SubjectsCompletedNCT01660295Phase 1/2
- A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell CarcinomaCompletedNCT01652547Phase 1
- Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell CarcinomaCompletedNCT01649778
- Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.CompletedNCT01649466Phase 4
- Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple SclerosisWithdrawnNCT01649050Phase 2
- A Study of Oral CFG920 in Patients With Castration Resistant Prostate CancerTerminatedNCT01647789Phase 1
- Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Pasireotide LAR in Patients With Castration Resistant Prostate CancerCompletedNCT01646684Phase 1
- Study of Safety and Preliminary Efficacy for LDK378 in Japanese Patients With Genetic Alterations in Anaplastic Lymphoma Kinase (ALK)CompletedNCT01634763Phase 1
- Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) PatientsCompletedNCT01634061Phase 1
- Safety and Pharmacokinetis of TAP311 in Dyslipidemic PatientsCompletedNCT01632358Phase 1
- 4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast CancerCompletedNCT01626222Phase 3
- A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid TumorsCompletedNCT01626209Phase 1
- Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).TerminatedNCT01624636Phase 2
- ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against InterferonWithdrawnNCT01621269Phase 4
- Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763CompletedNCT01619332Phase 1/2
- A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine PreventionWithdrawnNCT01617941Phase 2
- A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) PatientsCompletedNCT01613976Phase 1
- PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric CancerCompletedNCT01613950Phase 1
- Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal ImpairmentCompletedNCT01613690Phase 1
- Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical CancerWithdrawnNCT01613677Phase 2
- Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study TerminationNo longer availableNCT01613053
- A Phase I Study of LFA102 in Japanese PatientsCompletedNCT01610050Phase 1
- Trial Evaluating Nilotinib as Treatment for Newly Diagnosed CML Patients in Accelerated Phase.WithdrawnNCT01605981Phase 4
- Human Urine Sample Collection for Alport Nephropathy Biomarker StudiesTerminatedNCT01602835
- Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric CancerCompletedNCT01602406Phase 1
- A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic AdultsCompletedNCT01601600Phase 2
- Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord LesionsTerminatedNCT01598103Phase 2
- A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric CancerCompletedNCT01598077Phase 1
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of QGE031 in Japanese Atopic Male SubjectsCompletedNCT01596712Phase 1
- Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid TumorsCompletedNCT01596647Phase 1
- A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe HypertriglyceridemiaCompletedNCT01594983Phase 2
- Pharmacokinetics of LCQ908 in Patients With Hepatic ImpairmentCompletedNCT01594957Phase 1
- A Prospective, Open Label Study of CERtican in KIdney TransplantationCompletedNCT01594268Phase 4
- CAEB071 Thorough QTc Study in Healthy VolunteersCompletedNCT01594255Phase 1
- Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney DiseaseWithdrawnNCT01593527Phase 3
- Evaluate Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETsCompletedNCT01590199Phase 1
- Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes MellitusCompletedNCT01582230Phase 3
- A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy VolunteersCompletedNCT01578928Phase 1
- Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung CancerCompletedNCT01577654Phase 2
- Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsCompletedNCT01576666Phase 1
- A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma PatientsCompletedNCT01576380Phase 2
- Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy SubjectsCompletedNCT01568775Phase 1
- To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With AsthmaCompletedNCT01568762Phase 1
- Pharmacokinetics of LCQ908 in Patients With Renal ImpairmentCompletedNCT01558323Phase 1
- A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis PatientsCompletedNCT01552629Phase 2
- Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)CompletedNCT01546532Phase 2
- A Phase I Study of INC280 in Japanese Patients With Advanced Solid TumorsCompletedNCT01546428Phase 1
- Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic AnemiaCompletedNCT01546415Phase 4
- Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent AsthmaCompletedNCT01545726Phase 2
- Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart FailureCompletedNCT01543854Phase 2
- A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)CompletedNCT01542866Not applicable
- Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION)CompletedNCT01541956Phase 4
- Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.CompletedNCT01541189Phase 4
- Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic PatientsCompletedNCT01539915Phase 1
- Distribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mgCompletedNCT01539213Phase 1
- Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)CompletedNCT01535950Phase 2
- Pharmacokinetics of AGO178 in Participants With Liver ImpairmentCompletedNCT01531309Phase 1
- Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase InhibitorsCompletedNCT01529619Phase 4
- First in Human Trial of TAS266 in Patients With Advanced Solid TumorsTerminatedNCT01529307Phase 1